Form 4: Concentrix Corp CEO Sells Shares in Recent Transaction
SEC Form 4 Filing
Concentrix Corp's President and CEO, Christopher A. Caldwell, disposed of 6,574 shares of common stock on December 1, 2024.
Summary
- Christopher A. Caldwell, President and CEO of Concentrix Corp, sold 6,574 shares of common stock on December 1, 2024.
- The sale was executed at a price of $44.95 per share.
- Following the transaction, Mr. Caldwell directly owns 234,905 shares of Concentrix Corp stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction, a routine filing of an insider stock sale. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
- Similar filings are made by executives at companies like Accenture, Infosys, and Tata Consultancy Services when they trade their company's stock.
Stakeholder Impact
- The sale of shares by the CEO may have a minor impact on shareholder sentiment, but it is a common occurrence and not necessarily indicative of a negative outlook.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of the stock sale transaction. |
| 12/03/2024 | Date the form was signed by Andrew A. Farwig, Attorney-in-Fact. |
Keywords
Concentrix Corp, insider trading, stock sale, executive transaction, CNXC, Christopher A. Caldwell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.